Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine vs Midazolam for Sedation in Ventilated Children
NCT02509273Phase 3Terminated
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- May 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 3, randomised, double-blind trial of clonidine in sedation (2 arms), sponsored by FAU Erlangen-Nürnberg Medical Faculty. Primary endpoint: Proportion of subjects with sedation failure at 7 days. Started May 2016; status: terminated.
02
Drugs
clonidine
03
Conditions
sedation
Beyond the preview
Go deeper on NCT02509273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02509273.